BCAL Diagnostics Ltd

NEW
ASX:BDX (Australia)   Ordinary Shares
A$ 0.067 -0.0030 (-4.29%) Jul 31
At Loss
P/B:
9.57
Market Cap:
A$ 24.70M ($ 17.38M)
Enterprise V:
A$ 24.81M ($ 17.46M)
Volume:
219.35K
Avg Vol (2M):
518.83K
Trade In:
Volume:
219.35K
At Loss
Avg Vol (2M):
518.83K

BCAL Diagnostics Ltd (ASX:BDX) Dividend

BCAL Diagnostics Ltd (ASX:BDX) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -20.8%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ASX:BDX Dividend

Does BCAL Diagnostics Ltd (ASX:BDX) pay a dividend?

BCAL Diagnostics Ltd (ASX:BDX) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't BCAL Diagnostics Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. BCAL Diagnostics Ltd has returned capital to shareholders via buybacks at a rate of -20.8% over the past 3 years.

What are dividend-paying alternatives to BCAL Diagnostics Ltd?

For dividend-paying alternatives in BCAL Diagnostics Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.